A comprehensive view of CCL Industries Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

National Bank reaffirms CCL Industries at outperform and lifts target by C$1 to C$84, citing its acquisition of remaining 50% interest in Middle East JV Pacman-CCL; strategic move positions CCL to benefit from growth in region, adjacent frontier markets
Published: June 12, 2024 by Canada StockWatch
CCL Industries completes acquisition of remaining 50% equity in its Middle East venture, Pacman-CCL, from its partner Albwardy Investment for US$143M; business will immediately commence trading as CCL Label
Published: June 10, 2024 by Canada StockWatch
CCL Faubel Managing Director Frank Jager is appointed as commercial director of newly created CCL Clinical business unit that will specialize in pharmaceutical labels; Jager will oversee CCL's global business with the research-based pharmaceutical sector
Published: May 24, 2024 by CCL Faubel GmbH
Toronto Stock Exchange has accepted a notice filed by CCL Industries to commence a normal course issuer bid; under bid, CCL is authorized to acquire up to 14,750,000 of its Class B non-voting shares
Published: May 23, 2024 by CCL Industries Inc.
Scotia Capital maintains CCL Industries at sector outperform, lifts target C$1 to C$80; positive trends that should accelerate through 2024/2025 include several end-markets starting to rebound, positive RFID momentum, benefits from Innovia restructuring
Published: May 15, 2024 by Canada StockWatch

Ask us about our Sustainability & Social Responsibility market view

Trending Chart

Interactive chart with headline count